Pharmaxis eyes partner funding for LOXL2 inhibitor program; CEO to present at virtual health conference
Kazia Therapeutics to share pipeline results with market and clinicians
ShareRoot transforming into multi-platform digital healthcare company
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.